Education
About Us
Working with TipRanks
Follow Us
Sanara MedTech (SMTI)
NASDAQ:SMTI
SMTI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$25.90 - $39.08
Previous CloseN/A
Volume5.72K
Average Volume (3M)28.65K
Market Cap
$247.38M
Enterprise Value$299.16M
Total Cash (Recent Filing)$15.88M
Total Debt (Recent Filing)$1.60M
Price to Earnings (P/E)―
Beta1.07
Next Earnings
May 19, 2025EPS Estimate
-0.51Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.14
Shares Outstanding8,901,903
10 Day Avg. Volume38,558
30 Day Avg. Volume28,652
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.76
Price to Cash Flow (P/CF)35.80
P/FCF Ratio24.40
Enterprise Value/Market Cap1.21
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.81
Enterprise Value/Ebitda-160.82
Forecast
1Y Price Target
$48.50Price Target Upside76.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Sanara MedTech News
PremiumCompany Announcements
Sanara MedTech’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Sanara MedTech Reports Strong Revenue Growth in 2024
PremiumPre-Earnings
Is SMTI a Buy, Before Earnings?
PremiumCompany Announcements
Sanara MedTech Strengthens Leadership with New CFO Appointment
PremiumCompany Announcements
Sanara MedTech Secures U.S. Rights for OsStic---
Bulls Say, Bears Say
Bulls Say
LeadershipSanara has appointed Elizabeth Taylor as the Chief Financial Officer, bringing over 25 years of financial experience to the company.
Revenue GrowthRevenue grew 33%, driven by sales of soft tissue products in the Sanara Surgical segment.
Strategic AgreementsSanara entered an exclusive license and distribution agreement for a breakthrough device for fracture management.
Bears Say
Net LossThe company reported a net loss of $9.7M for FY2024, although it was less than the estimated loss.
Sales NormalizationApproximately $1.8M of BIASURGE sales was due to a unique situation (Hurricane Helene), and BIASURGE sales are expected to normalize.
---
Ownership Overview
52.49% Insiders
3.54% Mutual Funds
0.25% Other Institutional Investors
39.62% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SMTI FAQ
What was Sanara MedTech’s price range in the past 12 months?
Sanara MedTech lowest stock price was $25.90 and its highest was $39.08 in the past 12 months.
What is Sanara MedTech’s market cap?
Sanara MedTech’s market cap is $247.38M.
When is Sanara MedTech’s upcoming earnings report date?
Sanara MedTech’s upcoming earnings report date is May 19, 2025 which is in 40 days.
How were Sanara MedTech’s earnings last quarter?
Sanara MedTech released its earnings results on Mar 25, 2025. The company reported -$0.18 earnings per share for the quarter, missing the consensus estimate of -$0.115 by -$0.065.
Is Sanara MedTech overvalued?
According to Wall Street analysts Sanara MedTech’s price is currently Undervalued.
Does Sanara MedTech pay dividends?
Sanara MedTech does not currently pay dividends.
What is Sanara MedTech’s EPS estimate?
Sanara MedTech’s EPS estimate is -0.51.
How many shares outstanding does Sanara MedTech have?
Sanara MedTech has 8,901,903 shares outstanding.
What happened to Sanara MedTech’s price movement after its last earnings report?
Sanara MedTech reported an EPS of -$0.18 in its last earnings report, missing expectations of -$0.115. Following the earnings report the stock price went down -12.581%.
Which hedge fund is a major shareholder of Sanara MedTech?
Currently, no hedge funds are holding shares in SMTI
---
Sanara MedTech Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$48.50 (76.04% Upside)
$48.50 (76.04% Upside)
Blogger Sentiment
Bullish
SMTI Sentiment 100%
Sector Average 68%
Sector Average 68%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.80%
12-Months-Change
Fundamentals
Return on Equity
-22.95%
Trailing 12-Months
Asset Growth
19.25%
Trailing 12-Months
Company Description
Sanara MedTech
Sanara MedTech (SMTI) is a medical technology company focused on developing and commercializing products for wound and skin care. It operates in the healthcare sector, specifically targeting the advanced wound care market. The company's core products are designed to improve patient outcomes and include proprietary technologies for wound healing and infection prevention.
---
SMTI Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Sanara MedTech showcased strong revenue growth and profitability improvements, especially in the Sanara Surgical segment. The company expanded its market presence and strategic partnerships, contributing to positive financial performance. However, increased operating expenses and fourth-quarter net losses, especially in the Tissue Health Plus segment, present challenges. Overall, the sentiment of the call is positive, given the significant achievements and strategic advancements outweighing the financial setbacks.Read More>---
SMTI Stock 12 Month Forecast
Average Price Target
$48.50
▲(76.04% Upside)
Technical Analysis
Best Analysts Covering SMTI
1 Year
1 Year Success Rate
3/8 ratings generated profit
1 Year Average Return
+4.54%
reiterated a buy rating 15 days ago
Copying Ross Osborn's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of +4.54% per trade.
---